|
|
Media partners 
We work with leading magazines and publishers in this arena. If you are interested in becoming a media partner for this event please contact:
Julie Phillips, Marketing Manager
Email: julie.phillips@terrapinn.com
Tel: 02075394336
Fax: 02072421508
|
Piribo is the source for information products for the global biotechnology, healthcare and pharmaceutical industries.
Use Piribo to browse thousands of business information studies, market reports and books. Find the research you need in your work
EUROPEAN BIOTECHNOLOGY Science & Industry News:
The attractive information environment of this monthly published magazine constitutes of thoroughly researched news from science and industry, background reports on new EU legislation, current debates and financing initiatives from Brussels, as well as market analyses on the strengths and weaknesses of European biotech nations and previews on upcoming technology trends. With the European Biotechnology News journal you can address a competent an specialized readership in all 25 EU member states, as well as in Switzerland and Norway, predominantly in the major biotech clusters, in renowned European research institutions, as well as the current members of the 13 national scientific and corporate associations and readers in the biotechnology and Life Sciences industry sector.
BIOforum Europe provides the European biotechnology and life sciences markets with everything they need to know about the latest in research and development. It offers a pan-European platform for products and developments and therefore also the possibility of both setting up valuable new customer contacts as well as opening up new possibilities for cooperation. Its high-quality articles from the area of applied research, reports on new methods and applications, interviews, profiles of companies and bio regions, and news reports offer the ideal environment to reach the target customers.
PharmaDeals is the global resource that provides the latest analysis and information on deal making in the pharmaceutical industry. PharmaDeals is produced by PharmaVentures, the leading business consultancy specialising in pharmaceutical deal making. PharmaDeals includes databases, publications, surveys and deal analysis, presenting high quality and accurate business intelligence relating to past and future strategic alliances. The databases are accessible either via the Internet or CD-Rom. The information is consistently maintained to ensure the highest accuracy and quality. For further information, please contact Louise Parker on +44 (0) 1865 784 177, e-mail sales@pharmadeals.net or visit www.pharmaventures.com/pdeals.html
The Hungarian Biotechnology Association (HBA) was established by Hungary's leading human biotechnology companies to promote the development and representation of the Hungarian biotechnology sector. The Association's major objectives include obtaining support for the continued development of national life sciences and the commercialization of scientific achievements as well as representing Hungary at international exhibitions and conferences.
BioPharmaLife-India, the International publication is brought out as a bi-monthly to route the BIOTECH & PHARMA OUTSOURCING activities to India from US and Europe
BioPharmaLife contains up-to-date information on current outsourcing trends in areas of Drug Discovery, Development, Decease Research, Contract Research and manufacturing, Clinical Research, Clinical Trials, BioInformatics and related technology updates covering India, USA, Europe and Asia pacific regions, catering to both the buyers and service providers of Biotech and Pharma outsourcing. It includes in-depth articles, features, interviews, write-ups and extensive coverage of International Biotech & Pharma outsourcing conferences / exhibitions held worldwide.
Issue Highlights include Clinical Trials & Clinical Research market trends, Outsourcing Pharma R & D and manufacturing, Global Healthcare biotech opportunities, The Billion $$$ business of Drug Discovery and lots of Case studies
Thomson Pharma was developed to help pharmaceutical companies make better decisions faster.
It integrates information from Thomson Scientific with information from other Thomson sources, including the Financial, Healthcare and Legal and Regulatory groups. Thomson Pharma's core content areas include drug information, intellectual property data, literature and news, company data, chemical information, sequence data and drug target information, enhanced with value added content resources and powerful search tools. www.thomsonpharma.com
Every weekly issue of Cancer Drug News reports the important news on the companies, products, alliances and research that are shaping global cancer markets with regular sections on cancers affecting the brain, breast, GI tract, genito-urinary system, gynaecological system, blood and lung as well as melanoma/sarcoma.
For full details/sample issue: www.espicom.com/cdn
Drug Delivery Insight: a complete review of the latest commercial and product developments.
Drug Delivery Insight (DDI) takes the hard work out of staying in touch with the companies, products, alliances and research activities shaping the industry. For more information on DDI and to download your free copy visit http://www.espicom.com/ddi
Pharmalicensing is the world’s number one biopharmaceutical partnering resource, for executives involved with partnering, licensing and business development. Actively supporting in- and out-licensing activity, Pharmalicensing.com is used by over 32, 000 users each month.
A subscription to Partnering tools provides instant access to comprehensive information, including a company directory with over 6, 000 new and established companies, deals review and categorized news services.
Pharmalicensing’s business development reports provide key business intelligence to biopharma dealmakers.
London Technology Network (LTN) is funded by the UK Government, the European Union and three Regional Development Agencies (LDA, EEDA and SEEDA) and has the mission to “stimulate the transfer of technology-based innovation”.
LTN links companies worldwide with the technology research base and innovation capacity of the region’s academic and business communities. Since 2002, LTN has recruited a network of research scientists from over 130 leading research departments covering medical/life and computing/physical/engineering sciences and design. This gives LTN knowledge of, and access to, over 6,000 research scientists and their students. LTN works with these scientists, their colleagues and knowledge transfer offices to accelerate knowledge transfer between academia and industry.
LTN also operates the ‘London Innovation Relay Centre’ allowing it to match both innovation supply and innovation demand of London’s companies to partners throughout the EU.
Link to www.ltnetwork.org and www.london-irc.org
SCREENING - Trends in Drugs Discovery focuses new trends and developments in drug discovery. SCREENING covers all aspects of research as well as strategies of pharmaceutical companies and start-up companies. This editorial mixture makes for relevant reading for all those concerned with drug discovery. SCREENING - Trends in Drugs Discovery is published in English with 4 editions in 2006. For more information please contact Dr. Jutta van Empel at j.empel@gitverlag.com or tel. +49 6151 8090-139.
The Worldwide Organization for Collaborations in the Pharmaceutical Industry is dedicated to supporting collaborative arrangements in the Pharma and Biotech Industry.
W.O.C.P. was set up in response to the need in the industry for collaborations, including commercial transactions related to marketed products, such as co-promotion arrangements, expansion in new geographical territories, or product divestments or acquisitions, development compound alliances and partnering arrangements such as licensing, research collaborations, technology transfer deals (including university and academic institution - industry collaborations), as well as corporate transactions (e.g. M&A and strategic alliances).
W.O.C.P.'s remit is to facilitate partnering in the industry, collect, help develop and disseminate knowledge about best practices in dealmaking, improve communication and increase exposure of its members and the industry and widen the collaboration possibilities of its members around the world.
W.O.C.P.'s member benefits include a unique exposure to thousands of companies around the World and the executives that specialize in managing deals in their companies, the inclusion of detailed Corporate Overviews of every member organization and individual, a database of partnering opportunities that is set to grow (accessible to all, without limitation) as well as career advancement opportunities.
For more information, please visit www.wocp.org
|
|
|
|
